Skip to main content

Table 1 Clinicopathologic characteristics of PTC patients (n = 51)

From: NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells

Variable Category No. of cases % of cases
Gender Male 10 19.6
Female 41 80.4
Age ≤40 years 23 45.1
41–60 years 11 21.6
> 60 years 17 33.3
Type of surgery Total or near total thyroidectomy 42 82.4
Partial thyroidectomy 7 13.7
Others 2 3.9
Neck dissection Yes 27 52.9
No 24 47.1
Tumour size ≤4 cm 43 84.3
> 4 cm 8 15.7
Pathological stage of primary tumor size (pT) pT1 and pT2 22 43.1
pT3 and pT4 28 54.9
pTx 1 2.0
Pathological stage of regional lymph node (pN) pN1 30 58.8
pN2 3 5.9
pNx 18 35.3
Pathological stage of distant metastasis (pM) pM0 42 82.4
pM1 9 17.6
Pathological stage (pTNM) pTNM I 22 43.1
pTNM II 3 5.9
pTNM III 4 7.8
pTNM IV 15 29.4
Unknown 7 13.8
Histopathological classification Classic papillary carcinoma 40 78.2
Follicular variant 5 9.8
Tall cell variant 2 4.0
Clear cell variant 1 2.0
Solid variant 1 2.0
Oncocytic variant 1 2.0
Others 1 2.0
Extrathyroid extravasation Yes 30 58.8
No 18 35.3
Unknown 3 5.9
Vascular or angiolymphatic invasion Yes 23 45.1
No 22 43.1
Unknown 6 11.8
Morbidity outcome Without recurrence or persistence 21 41.2
Recurrence 9 17.6
Persistence 21 41.2
Place of outcome Without recurrence or persistence 21 41.2
Local and/or regional lesion only 11 21.6
Distant metastasis only 8 15.7
Both (Local and regional lesion and distant metastasis) 10 19.6
Unknown 1 1.9
Lethality within 10 years follow-up Yes 8 15.7
No 43 84.3
Cause of death PTC 6 75
Others 2 25